Impact of new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction
NOAF was detected in almost 1 out of 10 STEMI patients and was associated with a higher rate of stroke, major bleeding, and death as in patients with no AF and with similar rates compared with prior AF. Future studies assessing optimal anticoagulation therapy in this challenging patient population are warranted.
Authors
- Gregor Leibundgut (ORCID: https://orcid.org/0000-0002-0122-5397)
- Philipp Krisai (ORCID: https://orcid.org/0000-0002-4367-2363)
- Gábor Bari (ORCID: https://orcid.org/0000-0003-4167-5736)
- Stefan Osswald (ORCID: https://orcid.org/0000-0002-9240-6731)
- Judith Minder
- Michael Kühne (ORCID: https://orcid.org/0000-0002-2937-3711)
- Thomas Nestelberger (ORCID: https://orcid.org/0000-0003-2173-5738)
- Diego Mannhart (ORCID: https://orcid.org/0000-0003-0408-8313)
- Patrick Badertscher (ORCID: https://orcid.org/0000-0001-9751-0557)
- Sven Knecht (ORCID: https://orcid.org/0000-0001-7122-021X)
- Jasper Boeddinghaus (ORCID: https://orcid.org/0000-0003-4404-4956)
- Christian Sticherling (ORCID: https://orcid.org/0000-0001-8428-7050)
- Christoph Ado Kaiser (ORCID: https://orcid.org/0000-0002-8520-5253)
- Christian Eugen Mueller (ORCID: https://orcid.org/0000-0002-1120-6405)
- S. Brunner
Institutions
- University Hospital of Basel (CH)
- Hospital Base (CL)
Publication Details
- Journal
- Journal of Interventional Cardiac Electrophysiology
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1007/s10840-024-01941-5
- Citations
- 3
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.21
Funders
- National Science Foundation
- Amgen
- Pfizer
- Sanofi
- Edwards Lifesciences
- Foundation for Cardiovascular Research
- Universität Basel
- Boston Scientific Corporation
- Universitätsspital Basel
- Singulex
- European Commission
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Schweizerische Herzstiftung
- Gottfried und Julia Bangerter-Rhyner-Stiftung
- Schweizerische Akademie der Medizinischen Wissenschaften
- Medizinische Abteilung der Margarete und Walter Lichtenstein-Stiftung
- Idorsia Pharmaceuticals
- Sphingotec GmbH
- MicroPort
- Biosense Webster
- Daiichi Sankyo Europe